“The fact that most Zika virus infections do not result in symptoms serious enough to seek medical advice highlights the urgency to educate potential Zika virus infection victims to get tested, in particular, if they are pregnant mothers or partners of a pregnant mother,” said Dr. Ahmed Kilani, President and Laboratory Director at Clongen Labs. Clongen Laboratories offers molecular detection-based tests for Zika, Dengue, and Chikungunya viruses. All three viruses are transmitted by Aedes species mosquitoes and present with similar symptoms. “The latest test offerings are in line with our long-term objectives to stay ahead of the curve and use cutting-edge technologies for detection of new and re-emerging pathogens,” Kilani added. While serology tests may result in cross-reactivity among flaviviruses, particularly between Zika and Dengue viruses, molecular diagnostic tools designed to detect highly conserved and specific regions of the viral genomes afford a much greater specificity and sensitivity.